Home / Companies / Sangamo Therapeutics, Inc. / 12 Jun 2025
Sangamo Therapeutics, Inc.: meeting of 12 Jun 2025
Votes reported on Form N-PX, item by item
124 Form N-PX filers reported votes at the Sangamo Therapeutics, Inc. meeting of 12 Jun 2025. Their records fall into 4 items below, in ballot order: management items first, then proposals from security holders. Each bar shows how the reporting filers split; it is not the result of the meeting.
foragainstabstain, withhold or otheramber tick: the portion cast against management
Items
DIRECTOR ELECTIONSIssuer
Director elections
9 nominees; 99.5% of reported votes for; 2 filers withheld from or voted against at least one nominee.
369 vote records from 27 filers. 0 of the 27 filers that marked the item either way voted against management.
SECTION 14A SAY-ON-PAY VOTESIssuer
Advisory vote on executive pay (say-on-pay)
148 vote records from 122 filers. 1 of the 116 filers that marked the item either way voted against management. 6 filers reported this item without a management mark.
AUDIT-RELATEDIssuer
Audit-related items (auditor ratification)
41 vote records from 27 filers. 0 of the 27 filers that marked the item either way voted against management.
COMPENSATIONIssuer
COMPENSATION: management items
Management items in this category are shown together; filers word and number them differently.
42 vote records from 28 filers. 1 of the 28 filers that marked the item either way voted against management.
How the largest families voted
| Family | 1. Directors | 2. Say-on-pay | 3. Auditor |
|---|---|---|---|
| Vanguard | For | For | For |
| BlackRock and iShares | For | For | For |
| Fidelity | For | For | For |
| Dimensional | No report | For | No report |
| State Street and SPDR | For | For | For |
| Franklin Templeton | No report | For | No report |
| Invesco | For | For | For |
| Charles Schwab | For | For | For |
| John Hancock and Manulife | For | For | For |
| Morgan Stanley, Eaton Vance and Calvert | No report | For | No report |
| Goldman Sachs | For | For | For |
| PGIM and Prudential | No report | For | No report |
| Jackson National funds | For | For | For |
| Northern Trust and FlexShares | No report | For | No report |
| SEI | No report | For | No report |
| Lincoln Financial | For | For | For |
| Russell Investments | For | For | For |
| Victory Capital | For | For | For |
| Guggenheim and Rydex | For | For | For |
| BNY Mellon | No report | For | No report |
| Global X | For | For | For |
| Macquarie and Delaware Funds | For | For | For |
| Baird | No report | For | No report |
* against management. A family's position is the way most of its reported shares were voted across its filers; "split" means no single position led. "No report" means none of the family's filers listed the item.
Questions
How did large funds vote at the Sangamo Therapeutics, Inc. meeting?
124 Form N-PX filers reported votes at the meeting of 12 Jun 2025. On say-on-pay, 1 of 116 voted against management (0.9%). The family table lists each of the largest families item by item.
Is this the meeting result?
No. These are the votes of funds and managers that file Form N-PX, counted by filer and by the shares they reported. The certified result, which includes every shareholder, is reported by Sangamo Therapeutics, Inc. on Form 8-K.
Why are director elections shown as counts only?
Director records name the nominee. This site does not publish pages or rows about individuals, so for director elections it keeps the number of nominees and the split of votes and discards the wording.
Every meeting on file for Sangamo Therapeutics, Inc.
Provenance: SEC EDGAR, Form N-PX and N-PX/A filings listing Sangamo Therapeutics, Inc. with a meeting date within three days of 12 Jun 2025. Proposal titles are the most common wording among filers and are replaced by the SEC category where a wording could name a person. Not verified by the SEC. Filings read through 30 Sep 2026.